Joined January 2015
Photos and videos
James Anderson retweeted
Antibiotic development “is a specialist field, and it takes a long time for people to build up that expertise. So again, there is an urgency to try and stop that brain drain before it's lost further.” Insightful @CIDRAP Q&A w/@AndersonJames34 cidrap.umn.edu/antimicrobial… #AMR
3
8
1,289
James Anderson retweeted
Fewer than 30 #antibiotics currently in development target #drugresistant bacteria identified by the @WHO as the highest priority. More in @sciam: buff.ly/401UctB
5
5
375
James Anderson retweeted
"This is an area of true need. There has not been a new #antibiotic approved for the treatment of S. aureus bacteremia for over 15 years," @DukeMedSchool’s Thomas Holland, MD, says. cidrap.umn.edu/antimicrobial…
10
15
1,648
James Anderson retweeted
This week, I am in New York for the United Nations General Assembly Week 🗽 With three High-Level Meetings on global health and half time for realising the Sustainable Development Goals, we now need to galvanise and look ahead to next year’s meeting on AMR 💊
21
59
3,785
James Anderson retweeted
6 Sep 2023
New @IPPSecretariat comment published by @TheLancet on delivering the #100DaysMission. It’s critical that we learn the right lessons from the #COVID19 response to better prepare for future pandemics. Read @IFPMA’s priorities here: ifpma.org/insights/five-prio…
“The global community should use lessons from the COVID-19 pandemic as a mandate for improved pandemic preparedness” #100DaysMission Science & Technology Expert Group & IPPS Deputy Head @charlie_baker23 in a new opinion piece for @TheLancet 🧪💊💉 thelancet.com/journals/lance…
2
6
537
James Anderson retweeted
8 Aug 2023
#Cancer and #AMR are interlinked, as cancer patients' weakened immune systems leave them unprepared to fight off superbugs. Incentives for #antibiotics R&D can help us address these "twin epidemics."⤵️bit.ly/45dB7WB

3
6
504
James Anderson retweeted
“As more drug-resistant diseases, such as #gonorrhea, staphylococcus infections and strains of tuberculosis become increasingly persistent, time is not on our side.” –@innovativemeds @pcfralick windsorstar.com/opinion/lett…
7
11
850
James Anderson retweeted
13 Aug 2023
Progress in #globalhealth means people can live longer and healthier lives. Our collaborations help drive different activities in low- and middle-income countries that contribute toward #UHC and #HealthforAll🌎. Explore them on globalhealthprogress.org/
1
3
285
James Anderson retweeted
Thanks to @CSEINDIA for organising a great discussion and for the invitation to take part! We need to collaborate, co-operate and innovate to solve the antibiotic development and access crisis. #AMR #stopsuperbugs #antibiotics #antibacterials #pushfunding #pullincentives
Replying to @CSEINDIA
@CSEINDIA sounds dire warning on dipping #antibiotics #research. Our full package ⬇️ Press release🔗: rb.gy/xan3h Webinar on abx R&D crisis🔗:rb.gy/1hnmp @down2earthindia story🔗: rb.gy/7gq9e #AntimicrobialResistance #antibioticresistance #AMR
5
6
559
James Anderson retweeted
What could the next two decades of change look like in the infectious disease R&D ecosystem? New discussion paper from the @wellcometrust policy team sets out a vision for ambitious transformation - to help ensure we have the tools 💉💊🔬 we need to face 📈 infections 👇 (1/3)
30 May 2023
Infectious diseases account for a quarter of all global deaths. We need better vaccines, tests and drugs to reduce this burden. But the global research and development (R&D) system isn’t delivering them. That’s why we’re calling for reform ⤵️ wellcome.org/reports/towards…
1
9
23
8,141
James Anderson retweeted
16 May 2023
📢 Mark your calendars! On the sidelines of the #WHA76 (21-30 May, Geneva), IFPMA is organizing a series of events on #UHC, clinical trials, and #digitalhealth. Information are updated regularly on our website, check it out!👇 ifpma.org/events/
6
11
1,242
James Anderson retweeted
“If we don’t get some policy changes and develop the right financial incentives to reward risk taking,” CEO Henry Skinner said, “then the little innovation we have will, I think, dry up nearly completely.” #AMR ft.com/content/2730bf0a-91e6…
4
11
866
James Anderson retweeted
Policymakers must act now on #AMR “because, without timely interventions, investors will continue putting their money into other therapeutic areas; antibiotic companies will go bankrupt; and patients will continue suffering,” writes @JohnAlterIII globalcause.co.uk/infectious…
6
12
926
James Anderson retweeted
“No other class of drugs has served humanity’s collective interests like antibiotics have. Yet, they remain dangerously undervalued in today’s marketplace,” writes @HeideckerMartin #AMR healtheuropa.com/catalysing-… via @HealthEuropa
1
12
18
2,388
James Anderson retweeted
16 Mar 2023
Science & innovation delivered medical countermeasures to fight against #COVID19 in record time, but discussions on weakening IP protections risk hindering the #innovation system that enabled this in the first place. @ThomasCueni in @swissinfo_en⬇️ bit.ly/3YwSheg
5
8
1,396
Pleased to take part in this important meeting and share the progress made by the private sector as well as the asks we have to governments globally
Honoured to chair this week the 6th Meeting of the Global Leaders Group @GLGAMR on Antimicrobial Resistance @WHO @WOAH @FAO @UNEP
1
4
188
James Anderson retweeted
January is #OneHealthAwarenessMonth. Why does #OneHealth matter? Find out in our #infographic. Learn about OHT's future headquarters for One Health research, education, and action in our podcast with OHT's Ramanan Laxminarayan. Listen here: onehealthtrust.org/news-medi…
19
27
2,544
James Anderson retweeted
8 Jan 2023
We are pleased to see new international investments by the industry backed @AMRActionFund toward accelerating antibiotic R&D to #beatAMR. Now, global policymakers must also step up & take action toward the development of new #antibiotics. More in @axios ⬇️
6 Jan 2023
Everyone agrees that the world needs new antibiotics, as the number of drug-resistant infections continues to soar. But there's little agreement on how to finance their development. trib.al/vznUd4d
1
2
413
James Anderson retweeted
We are thrilled to announce our investment into @BioVersys! The antibiotics they are developing target some of the highest-priority drug-resistant pathogens and could deliver significant benefits to patients suffering from life-threatening infections. amractionfund.com/blog-2022/… #AMR
1
11
34
17,762
James Anderson retweeted
👏 Include vaccines in the fight against drug-resistant #superbugs. 👏 Let's say it louder for the folks in the back. Learn why in our OWOH #podcast with Dr. David Heymann of @LSHTM_AMR @LSHTM Listen here: onehealthtrust.org/news-medi… #fightamr #amr
22
35
7,138